Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Imatinib
Imatinib
152459-95-5
|
493.603
|
4.529
Imatinib is an oral chemotherapy medication used to treat cancer. It is a tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
Gleevac | IKT-001 | NSC 759854 | ST-1571 | STI-571 | gleevec | glivec | imatinib | imitinib
Imatinib is an oral chemotherapy medication used to treat cancer. It is a tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
Gleevac | IKT-001 | NSC 759854 | ST-1571 | STI-571 | gleevec | glivec | imatinib | imitinib
$19/5 mg
(EBC)
1
We provide 3 compounds for Imatinib
Imatinib impurity H CRS
1-(pyridin-3-yl)ethan-1-one
3-Acetylpyridine
350-03-8
121.053
0.48
$19/5 mg
(EBC)
1
Imatinib impurity A CRS
3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one
-
55314-16-4
176.095
1.196
$55/5 mg
(EBC)
1
Imatinib impurity F CRS
6-methyl-N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
6-Methyl-N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
152460-10-1
277.324
2.486
$19/5 mg
(EBC)
1